Andrew Hessel is a futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the changes ahead in life science. He is a Distinguished Researcher with Autodesk Inc. Bio/Nano Programmable Matter group, based out of San Francisco. He is also the cofounder of the Pink Army Cooperative, the world first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer.